Amylin receptor drugs for Type 2 Diabetes

3 tracked Amylin receptor drugs in the Type 2 Diabetes race. The class explanation lives on the Amylin receptor page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.

1 approved / phase 42 Phase 3

Head-to-head evidence: cagrilintide vs cagrilintide/semaglutide · cagrilintide/semaglutide vs pramlintide

The roster

← all Amylin receptor drugs